A phase III trial of bevacizumab + paclitaxel as a first-line therapy in patients with metastatic breast cancer.
Phase of Trial: Phase III
Latest Information Update: 18 Nov 2011
At a glance
- Drugs Bevacizumab; Paclitaxel
- Indications Breast cancer
- Focus Biomarker; Registrational; Therapeutic Use
- 18 Nov 2011 New trial record